You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prostatic Neoplasms

Showing 1 - 25 of 7,360
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostatic Tumors, Prostate Disease, Prostate Obstruction Trial in Shibin Al Kawm (Single dose tamsulosin 0.4mg, Double dose

Completed
  • Prostatic Neoplasms
  • +3 more
  • Single dose tamsulosin 0.4mg
  • Double dose tamsulosin 0.4mg
  • Shibīn Al Kawm, Menofia, Egypt
    Faculty of Medicine
Apr 17, 2023

Prostatic Cancer, TRUS Biopsy, Fusion MRI Targeted Biopsy Trial in Shibin Al Kawm (MRI fusion targeted prostatic biopsy, MRI

Recruiting
  • Prostatic Cancer
  • +3 more
  • MRI fusion targeted prostatic biopsy
  • MRI cognitive targeted prostatic biopsy
  • Shibin Al Kawm, Menoufia, Egypt
    Menoufia University Hospital
Jul 23, 2023

Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

Not yet recruiting
  • Androgen-Independent Prostatic Cancer
  • +8 more
  • lorigerlimab
  • +2 more
  • (no location specified)
May 4, 2023

Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA

Recruiting
  • Prostatic Neoplasms
  • Radical prostatectomy (RP)
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Jul 14, 2023

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023

Medicines Called Enzalutamide and Abiraterone in People With

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Pfizer Inc
Jul 21, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Prostatic Tumors, Castration-Resistant Trial in Multiple Locations (Radium-223 dichloride (Xofigo, BAY 88-8223))

Active, not recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radium-223 dichloride (Xofigo, BAY 88-8223)
  • Multiple Locations, Japan
    (unnamed)
Feb 2, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Learn About Novel Hormonal Therapies for Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Nov 21, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Quality of Life and Survival of Radical Prostatectomy

Not yet recruiting
  • Prostatic Neoplasms
  • +4 more
  • frailty
  • (no location specified)
Jul 9, 2023

Prostate Cancer, Prostatic Tumors Trial (64Cu-SAR-bisPSMA)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • (no location specified)
Sep 21, 2023

Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)

Not yet recruiting
  • Prostatic Adenocarcinoma
  • Seoul, Korea, Korea, Republic of
    Samsung Medical Center
Aug 23, 2023

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Prostatic Tumors, Castration-Resistant Trial in New York (TVB-2640, Enzalutamide)

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Feb 23, 2023

Prostatic Tumors Trial (Prostate SBRT with Focal Boost, Triptorelin Injection)

Not yet recruiting
  • Prostatic Neoplasms
  • Prostate SBRT with Focal Boost
  • Triptorelin Injection
  • (no location specified)
May 1, 2023

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a

Recruiting
  • Prostate Cancer
  • +4 more
  • Performing cognitive prostate biopsy with a radiologist's guidance with map
  • Performing cognitive prostate biopsy without a radiologist's guidance with map
  • Istanbul, Turkey
    Marmara University, School of Medicine, Department of Urology
Jun 5, 2023

Lower Urinary Tract Symptoms, Prostatic Hyperplasia, Prostatic Cancer Trial in Madrid (Temporary prostatic stent (Exime®),

Not yet recruiting
  • Lower Urinary Tract Symptoms
  • +3 more
  • Temporary prostatic stent (Exime®)
  • Indwelling catheter
  • Madrid, Spain
    Juan Ignacio Martinez-Salamanca
May 1, 2023

Prostate Cancer, Prostatic Tumors Trial in Boston (PROWESS)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • PROWESS
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 22, 2023

Benign Prostatic Hyperplasia, Localized Prostate Cancer Trial in Hong Kong, Beirut (Robotic Waterjet Treatment)

Recruiting
  • Benign Prostatic Hyperplasia
  • Localized Prostate Cancer
  • Robotic Waterjet Treatment
  • Hong Kong, Hong Kong
  • +1 more
Sep 18, 2023

Treatment Satisfaction With Ra-223 in Japan

Active, not recruiting
  • Prostatic Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, Japan
    Many Locations
Jan 12, 2023

Men at High Genetic Risk for Prostate Cancer

Recruiting
  • Prostatic Neoplasms
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Men of African Ancestry Using MRI and MRI Guided Biopsy

    Not yet recruiting
    • Prostate Specific Antigens
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      May 31, 2023